Leukemia Research
Volume 27, Issue 5 , Pages 437-444, May 2003

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

  • Sepideh Shaker

      Affiliations

    • Centre de Recherche Pédiatrique, Hôpital Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Quebec, Canada, H3T 1C5
    • ,
  • Mark Bernstein

      Affiliations

    • Département de Pharmacologie, Université de Montréal, and Service d’Hématologie-Oncologie, Montréal, Quebec, Canada, H3T 1C5
    • ,
  • Louise F Momparler

      Affiliations

    • Centre de Recherche Pédiatrique, Hôpital Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Quebec, Canada, H3T 1C5
    • ,
  • Richard L Momparler

      Affiliations

    • Centre de Recherche Pédiatrique, Hôpital Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Quebec, Canada, H3T 1C5
    • Corresponding Author InformationCorresponding author. Tel.: +1-514-345-4931; fax: +1-514-345-4801.

Received 30 May 2002; accepted 28 September 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(02)00222-9

doi:10.1016/S0145-2126(02)00222-9

Leukemia Research
Volume 27, Issue 5 , Pages 437-444, May 2003

Article Tools

* Image Usage & Resolution